5 Key Takeaways

• 1

  The Calibreye system shows promise for significant intraocular pressure (IOP) and medication reduction in glaucoma patients.

• 2

  The feasibility study involved 43 patients across four countries, with 33 completing at least 3 months of follow-up.

• 3

  Results indicated a 44.9% reduction in IOP, averaging 12.1 mmHg, and 88% of patients were medication-free post-surgery.

• 4

  The device allows for in-office adjustments using a laser to control aqueous flow resistance and prevent hypotony.

• 5

  Safety data was generally as expected, with one device explanted due to hypotony maculopathy, leading to technique adjustments.